Clarifying Information for Quarterly Reporting of Medicaid Drug Rebates in the Medicaid Budget and Expenditure System (MBES)
Guidance for : This informational bulletin is to provide information to states on reporting Medicaid drug rebates on the Quarterly Medicaid Statement of Expenditures for the Medical Assistance Program (the CMS-64) in the Medicaid Budget and Expenditure System (MBES). The combination of CMS reviews of state drug rebate reporting, state requests for clarification, HHS Office of Inspector General Audits, and new Medicaid matching rates available through the Affordable Care Act all underscore the need for CMS to issue this clarifying information to states.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: July 24, 2014
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.